After Astrazeneca, Denmark is now also removing the corona vaccine from Johnson & Johnson from its vaccination plan. The reason for this is rare blood clots.
Copenhagen – In Denmark *, the corona vaccine from the manufacturer Johnson & Johnson is now to be deleted from the vaccination program. The country’s health authority announced on Monday. The background to this is the possible side effects of the vaccine in the form of severe blood clots. The advantages of a vaccination could not offset this risk, it said in a statement from the authority. Astrazeneca’s active ingredient had previously been dropped from the vaccination program.
In April, the European Medicines Agency (EMA) found a possible link between the Johnson & Johnson preparation and rare but severe cases of blood clots. Such a connection had previously also been established with the award of the Astrazeneca vaccine Vaxzevria. Although the EMA continues to recommend the use of both means to combat the corona pandemic, Denmark decided to remove the Astrazeneca * active ingredient from the vaccination program.
Astrazeneca vaccine can be used in Denmark for volunteers
A political majority in parliament on Monday voted for Vaxzevria to be administered to volunteers.
The decision to take the second vaccine out of the program has consequences for the Corona * vaccination campaign, as the authority further announced. According to the Ritzau agency, Denmark had ordered a particularly large amount of the Johnson & Johnson vaccine, as only one dose of this preparation was required. The 25 to 39 year olds should expect to get their first dose four weeks later. (dpa) * Merkur.de is an offer from IPPEN.MEDIA.
